The U.S. Food and Drug Administration (FDA) and drug manufacturer Novo Nordisk are warning consumers about “counterfeit” ...

Accordingly, neither Novo Nordisk ... needles cannot be confirmed, which presents an increased risk of infection for patients who use counterfeit products. Based on analyses completed to date ...

Alternative compounded versions of Novo Nordisk’s blockbuster weight-loss and diabetes drugs have hurt its sales, ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...

The FDA and drugmaker Novo Nordisk ... needles, which means the FDA could not certify that the needles are sterile and not a risk of infection. Patients should double-check their Ozempic ...

A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes.

Patients should only obtain Ozempic with a valid prescription through state-licensed pharmacies and check the product for counterfeiting before using, Novo Nordisk advised. There have been six ...

A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic ...